Literature DB >> 19443672

Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.

Ferdinando Frigeri, Manuela Arcamone, Luigia Luciano, Raffaele Di Francia, Fabrizio Pane, Antonio Pinto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443672     DOI: 10.1182/blood-2008-11-191080

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Primary isolated central nervous system acute lymphoblastic leukemia with BCR-ABL1 rearrangement: A case report.

Authors:  Yan Chen; Quan-Yi Lu; Jing-Yuan Lu; Xiu-Li Hong
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

2.  Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report.

Authors:  Shiue-Wei Lai; Tzu-Chuan Huang; Jia-Hong Chen; Yi-Ying Wu; Ping-Ying Chang
Journal:  Oncol Lett       Date:  2015-02-03       Impact factor: 2.967

3.  Isolated central nervous system blast crisis in a case of chronic myeloid leukemia on dasatinib.

Authors:  P K Kiran; Girish V Badarke; C N Suresh; B J Srinivas; Radheshyam Naik
Journal:  South Asian J Cancer       Date:  2018 Jul-Sep

4.  Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice.

Authors:  Karthik Ravi; Andrea Franson; Morgan J Homan; Holly Roberts; Manjunath P Pai; Zachary Miklja; Miao He; Bo Wen; Lydia L Benitez; Anthony J Perissinotti; Dale L Bixby; Carl Koschmann; Bernard L Marini
Journal:  Leuk Lymphoma       Date:  2021-03-07

5.  Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.

Authors:  Ahmed A Bin Salman; Abdul Rehman Zia Zaidi; Syed Yasir Altaf; Nawal F AlShehry; Imran K Tailor; Ibraheem H Motabi; Syed Ziauddin A Zaidi
Journal:  Am J Case Rep       Date:  2020-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.